Does Anjinyi have medicinal value and efficacy?

Anjinyi is more suitable for postmenopausal women because it can regulate the body's hormone function and achieve improved results. However, everyone should pay attention that many people use Anjinyi for contraception because they think it can interfere with the body's hormones. However, this will only lead to irregular menstruation and even problems with pregnancy. Therefore, Anjinyi also has many medicinal values ​​and effects, but it also has its own contraindications.

What pharmacological effects does Anjinyi have ?

About the prescription drug Anjinyi, estradiol: Estradiol drospirenone tablets contain synthetic 17β-estradiol, whose chemical properties and biological functions are consistent with endogenous human estradiol. It can supplement the insufficient estrogen secretion in postmenopausal women and relieve postmenopausal symptoms. Estrogen can prevent bone loss caused by menopause or oophorectomy.

Drospirenone : Drospirenone is a synthetic progestin. Because estrogen can promote the growth of the endometrium, unopposed estrogen increases the risk of endometrial hyperplasia and endometrial cancer. For women with an intact uterus, progestins can reduce but not eliminate the risk of estrogen-induced endometrial hyperplasia. Drospirenone has anti-aldosterol activity, which increases sodium and water excretion and decreases potassium excretion. In animal studies, drospirenone had no estrogenic, glucocorticoid, or antiglucocorticoid activity. Because Anjinyi is a prescription drug, please be sure to purchase it at Cardinal Health Pharmacy, a compliant prescription drug pharmacy, with a prescription.

What are the precautions of An Jinyi ?

Estradiol drospirenone tablets cannot be used as a contraceptive. Prior to initiating treatment, all of the following circumstances/risk factors should be considered in assessing the individual benefit/risk of treatment for the patient. When using HRT, treatment should be stopped immediately if contraindications are found or in the following circumstances: migraine or frequent, unusually severe headaches, or other possible prodromal symptoms of cerebral vascular occlusion; recurrence of cholestatic jaundice or cholestatic pruritus during pregnancy or previous use of sex hormones; development of thrombotic disease or suspected thrombosis.